Chemed CorporationCHENYSE
Loading
EBITDA Over TimeStable
Percentile Rank86
3Y CAGR+2.4%
5Y CAGR-1.5%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+2.4%/yr
vs +8.5%/yr prior
5Y CAGR
-1.5%/yr
Recent acceleration
Acceleration
-6.1pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive declineStable
PeriodValueYoY Change
2025$422.37M-9.0%
2024$464.29M+12.1%
2023$414.34M+5.3%
2022$393.44M-4.3%
2021$411.23M-9.6%
2020$454.93M+46.1%
2019$311.35M+9.8%
2018$283.45M+80.8%
2017$156.81M-27.2%
2016$215.41M-